LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production

Our previously study shown that Lysophosphatidylcholine Acyltransferase1 (LPCAT1) is overexpressed in castration resistant prostate cancer (CRPC) relative to primary prostate cancer (PCa), and androgen controls its expression via the Wnt signaling pathway. While highly expressed in CRPC, the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Chao, Yu, Guopeng, Mao, Yuanshen, Song, Shangqing, Li, Long, Zhou, Lin, Wang, Zhong, Liu, Yushan, Li, Minglun, Xu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605678/
https://www.ncbi.nlm.nih.gov/pubmed/33137125
http://dx.doi.org/10.1371/journal.pone.0240801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605678/
https://www.ncbi.nlm.nih.gov/pubmed/33137125
http://dx.doi.org/10.1371/journal.pone.0240801

Ejemplares similares